Adoptively transferred tumor-specific T cells expanded ex vivo using HSV amplicons encoding 4-1BBL show increased anti-tumor activity in vivo

被引：0
|
作者：
Yi, Kyung H.
Nechushtan, Hovav
Zhang, Yu
Bowers, William J.
Federoff, Howard J.
Pham, Dien G.
Podack, Eckhard R.
Rosenblatt, Joseph D.
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Rochester, Rochester, NY USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4757
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ADOPTIVELY TRANSFERRED EX-VIVO ACTIVATED MEMORY T-CELLS WITH CYCLOPHOSPHAMIDE - EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTATIC MURINE MELANOMA AND CARCINOMA (VOL 73, PG 115, 1994)
    GOLD, JE
    ZACHARY, DT
    OSBAND, ME
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (01): : 105 - 105
  • [22] ANTI-TUMOR IN VIVO EFFICACY OF T CELLS TRANSDUCED WITH MAGE-A4-SPECIFIC αβ TYPE TCR GENES
    Ikeda, Hiroaki
    Shirakura, Yoshitaka
    Hirayama, Michiko
    Hiasa, Atsunori
    Nishikawa, Hiroyoshi
    Kitano, Shigehisa
    Tajima, Kazuo
    Nukaya, Ikuei
    Yu, Shen Sin
    Mineno, Junichi
    Ito, Mamoru
    Kato, Ikunoshin
    Shiku, Hiroshi
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1163 - 1163
  • [23] Human Plasma Cells Engineered to Produce Bi-Specific T Cell Engagers Show In Vivo Anti-Tumor Efficacy
    Hill, Tyler
    Narvekar, Parnal
    Asher, Gregory
    Camp, Nathan
    Thomas, Kerri
    Tasian, Sarah
    Rawlings, David J.
    James, Richard
    MOLECULAR THERAPY, 2023, 31 (04) : 290 - 290
  • [24] In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)
    Durai, Malarvizhi
    Krueger, Christine
    Ye, Zhaohui
    Cheng, Linzhao
    Mackensen, Andreas
    Oelke, Mathias
    Schneck, Jonathan P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (02) : 209 - 220
  • [25] In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)
    Malarvizhi Durai
    Christine Krueger
    Zhaohui Ye
    Linzhao Cheng
    Andreas Mackensen
    Mathias Oelke
    Jonathan P. Schneck
    Cancer Immunology, Immunotherapy, 2009, 58 : 209 - 220
  • [26] Dendritic cells enhance the function of ex vivo expanded tumor specific CD4 T cells from neu Transgenic mice
    Dang, Yushe
    Gad, Ekram
    Lai, Vy P.
    Cohen, Peter A.
    Disis, Mary L.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 856 - 856
  • [27] Ex vivo-activated allogeneic CD4+ T-cells disrupt immunosuppressive tumor microenvironment, and induce host tumor-specific cytotoxic T-cells in mice
    Mochizuki, Kazuhiro
    Kobayashi, Shogo
    Takahashi, Nobuhisa
    Sano, Hideki
    Ohara, Yoshihiro
    Mineishi, Shin
    Zhang, Yi
    Kikuta, Atsushi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] Ex vivo-induction of tumor-specific effector and memory T cells for adoptive T cell therapies using antigen-loaded DCs
    Hansen, Morten
    Wieckowski, Eva
    Kalinski, Pawel
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [29] Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo
    Cao, Yu
    Feng, Yong-Hui
    Gao, Li-Wei
    Li, Xiao-Ying
    Jin, Quan-Xiu
    Wang, Yu-Ying
    Xu, Ying-Ying
    Jin, Feng
    Lu, Shi-Long
    Wei, Min-Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 70 : 110 - 116
  • [30] Differences in the phenotype and in vivo anti-tumor activity of wti specific and ebv-specific T-cells generated in vitro for adoptive immunotherapy
    Doubrovina, E
    Dupont, J
    Kanaeva, E
    Doubrovin, M
    O'Reilly, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 87 - 87
12345